AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-140540864/neose-provides-update-ne.html" title="Facts and information about Neose provides update on NE-180 programme.">Neose provides update on NE-180 programme.</a>
Close
Set up an RSS feed that alerts you when new articles from Chemical Business Newsbase are available.
Frequently asked questions about RSS feeds
Neose provides update on NE-180 programme.
(From Chemical Business NewsBase - Press Release)
Neose Technologies Inc (Neose) provided an update on its NE-180 (GlycoPEG-EPO) programme. The company has been pursuing parallel efforts in the US and Europe to move its NE-180 candidate into clinical trials. As part of its NE-180 development strategy, the company recently filed for authorisation to commence a Phase I clinical trial in a European regulatory jurisdiction. Subject to approval, the company is …
Related articles from newspapers, magazines, journals, and more
-
- Neose receives FDA clearance to commence US clinical trials for NE-180.
-
News wire article from: Chemical Business Newsbase
March 15, 2007
700+ words
-
- Q4 2006 Neose Technologies Earnings Conference Call - Final.
-
News wire article from: Fair Disclosure Wire
March 19, 2007
700+ words
-
- Q3 2007 Neose Technologies Earnings Conference Call - Final.
-
News wire article from: Fair Disclosure Wire
November 8, 2007
700+ words
-
- Q1 2007 Neose Technologies Earnings Conference Call - Final.
-
News wire article from: Fair Disclosure Wire
May 3, 2007
700+ words
-
- Q1 2008 Neose Technologies Earnings Conference Call - Final.
-
News wire article from: Fair Disclosure Wire
May 8, 2008
700+ words
